Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes.

Literature DB >> 16557946

Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes.

Abstract

Passive-protection tests were conducted in mice with antisera from rabbits immunized with formalinized or heat-killed cells or with an alcohol-precipitated fraction from the slime layer. Protection was conferred by antisera against the heatstable antigens and correlated well with agglutinin levels. Specificity was found to relate closely to the heat-stable "O" serotypes as defined by Verder and Evans.

Entities: Chemical Disease Species

Year: 1971 PMID： 16557946 PMCID： PMC416106 DOI： 10.1128/iai.3.1.51-58.1971

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

25 in total

1. EVALUATION OF ANTIBIOTIC PROPHYLAXIS AND GAMMA-GLOBULIN, PLASMA, ALBUMIN AND SALINE-SOLUTION THERAPY IN SEVERE BURNS. BACTERIOLOGIC AND IMMUNOLOGIC STUDIES.

Authors: N A KEFALIDES; J A ARANA; A BAZAN; N VELARDE; S M ROSENTHAL
Journal: Ann Surg Date: 1964-04 Impact factor: 12.969

2. PSEUDOMONAS INFECTION. TREATMENT WITH IMMUNE PLASMA.

Authors: D S FEINGOLD; F OSKI
Journal: Arch Intern Med Date: 1965-09

3. A proposed antigenic schema for the identification of strains of Pseudomonas aeruginosa.

Authors: E VERDER; J EVANS
Journal: J Infect Dis Date: 1961 Sep-Oct Impact factor: 5.226

4. Measurement of the protective effect of antibody in burned and unburned patients' sera for Pseudomonas aeruginosa infected mice.

Authors: C D GRABER; D CUMMINGS; E H VOGEL; W T TUMBUSCH
Journal: Tex Rep Biol Med Date: 1961

5. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors: P V LIU; Y ABE; J L BATES
Journal: J Infect Dis Date: 1961 Mar-Apr Impact factor: 5.226

6. Prevalence of antibody to Pseudomonas in normal human sera.

Authors: S GAINES; M LANDY
Journal: J Bacteriol Date: 1955-06 Impact factor: 3.490

7. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.

Authors: R J Jones
Journal: Br J Exp Pathol Date: 1968-10

6. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.

Authors: A B Bjornson; J G Michael
Journal: Infect Immun Date: 1972-05 Impact factor: 3.441

7. Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria.

Authors: J L Penner; G R Whiteley
Journal: Infect Immun Date: 1978-05 Impact factor: 3.441

8. Slime of Pseudomonas aeruginosa: in vivo production.

Authors: G Dimitracopoulos; J W Sensakovic; P F Bartell
Journal: Infect Immun Date: 1974-07 Impact factor: 3.441

8 in total

Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes.

1. EVALUATION OF ANTIBIOTIC PROPHYLAXIS AND GAMMA-GLOBULIN, PLASMA, ALBUMIN AND SALINE-SOLUTION THERAPY IN SEVERE BURNS. BACTERIOLOGIC AND IMMUNOLOGIC STUDIES.

2. PSEUDOMONAS INFECTION. TREATMENT WITH IMMUNE PLASMA.

3. A proposed antigenic schema for the identification of strains of Pseudomonas aeruginosa.

4. Measurement of the protective effect of antibody in burned and unburned patients' sera for Pseudomonas aeruginosa infected mice.

5. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

6. Prevalence of antibody to Pseudomonas in normal human sera.

7. Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.

8. Susceptibility of man to Pseudomonas aeruginosa.

9. Evaluation of gamma globulin for prophylaxis against burn sepsis.

10. Protection by vaccination against Pseudomonas infection after thermal injury.

1. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.

2. Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.

3. Passive immunity against pseudomonas sepsis during granulocytopenia.

4. Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.

Review 5. Cystic fibrosis. Infection and immunity to Pseudomonas.

6. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. II. Opsonic, agglutinative, and protective capacities of immunoglobulin G anti-Pseudomonas antibodies.

7. Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria.

8. Slime of Pseudomonas aeruginosa: in vivo production.